2017-09-27 |
2017-09-25 |
S
Sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
4,228
-8.5%
179.66
759,619
USD
|
4,228
-8.5%
|
179.66
|
759,619
USD
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
Wiezorek Jeffrey
SVP Clinical Development
|
5,283
-17.0%
179.66
949,164
USD
|
5,283
-17.0%
|
179.66
|
949,164
USD
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
JENKINSON PAUL L
Chief Financial Officer
|
948
-9.1%
179.66
170,321
USD
|
948
-9.1%
|
179.66
|
170,321
USD
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
4,228
-3.4%
179.66
759,619
USD
|
4,228
-3.4%
|
179.66
|
759,619
USD
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
Belldegrun Arie
Chairman, President and CEO
Executive Director
|
26,347
-19.4%
179.66
4,733,605
USD
|
26,347
-19.4%
|
179.66
|
4,733,605
USD
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
Kim Helen Susan
EVP, Business Development
|
3,171
-12.8%
179.66
569,714
USD
|
3,171
-12.8%
|
179.66
|
569,714
USD
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
Tomasello Shawn
Chief Commercial Officer
|
4,203
-6.4%
179.66
755,127
USD
|
4,203
-6.4%
|
179.66
|
755,127
USD
|
|
2017-09-27 |
2017-09-25 |
S
Sale
|
Chang David D
EVP, R&D, Chief Medical Off.
|
7,927
-12.1%
179.66
1,424,196
USD
|
7,927
-12.1%
|
179.66
|
1,424,196
USD
|
|
2017-08-14 |
2017-08-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
5,800
-4.7%
121.03
701,974
USD
|
5,800
-4.7%
|
121.03
|
701,974
USD
|
|
2017-08-14 |
2017-08-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
9,200
-6.9%
120.52
1,108,784
USD
|
9,200
-6.9%
|
120.52
|
1,108,784
USD
|
|
2017-08-14 |
2017-08-10 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
6,251
-25.1%
120.09
750,683
USD
|
6,251
-25.1%
|
120.09
|
750,683
USD
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
13,274
-41.6%
121.37
1,611,065
USD
|
13,274
-41.6%
|
121.37
|
1,611,065
USD
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
31,165
-49.4%
120.40
3,752,266
USD
|
31,165
-49.4%
|
120.40
|
3,752,266
USD
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
18,936
-23.1%
119.94
2,271,184
USD
|
18,936
-23.1%
|
119.94
|
2,271,184
USD
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
3,800
-4.4%
118.61
450,718
USD
|
3,800
-4.4%
|
118.61
|
450,718
USD
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
1,700
-1.9%
117.27
199,359
USD
|
1,700
-1.9%
|
117.27
|
199,359
USD
|
|
2017-08-10 |
2017-08-08 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
11,074
-11.2%
115.02
1,273,731
USD
|
11,074
-11.2%
|
115.02
|
1,273,731
USD
|
|
2017-08-04 |
2017-08-03 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
5,131
-9.4%
110.05
564,667
USD
|
5,131
-9.4%
|
110.05
|
564,667
USD
|
|
2017-08-04 |
2017-08-03 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
869
-1.6%
110.10
95,677
USD
|
869
-1.6%
|
110.10
|
95,677
USD
|
|
2017-08-03 |
2017-08-01 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
321
-0.6%
109.35
35,101
USD
|
321
-0.6%
|
109.35
|
35,101
USD
|
|
2017-08-03 |
2017-08-01 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
3,771
-7.0%
108.27
408,286
USD
|
3,771
-7.0%
|
108.27
|
408,286
USD
|
|
2017-08-03 |
2017-08-01 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
5,431
-9.2%
107.58
584,267
USD
|
5,431
-9.2%
|
107.58
|
584,267
USD
|
|
2017-08-03 |
2017-08-01 |
PS
Planned sale
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
2,477
-4.0%
106.85
264,667
USD
|
2,477
-4.0%
|
106.85
|
264,667
USD
|
|
2017-08-01 |
2017-07-31 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
672
-3.5%
111.60
74,995
USD
|
672
-3.5%
|
111.60
|
74,995
USD
|
|
2017-08-01 |
2017-07-31 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
2,725
-12.4%
110.55
301,249
USD
|
2,725
-12.4%
|
110.55
|
301,249
USD
|
|
2017-08-01 |
2017-07-31 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
7,448
-25.2%
109.74
817,344
USD
|
7,448
-25.2%
|
109.74
|
817,344
USD
|
|
2017-08-01 |
2017-07-31 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
15,804
-34.9%
108.75
1,718,685
USD
|
15,804
-34.9%
|
108.75
|
1,718,685
USD
|
|
2017-07-11 |
2017-07-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
Officer
|
5,000
-4.1%
105.50
527,500
USD
|
5,000
-4.1%
|
105.50
|
527,500
USD
|
|
2017-07-11 |
2017-07-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
Officer
|
1,100
-0.9%
102.81
113,091
USD
|
1,100
-0.9%
|
102.81
|
113,091
USD
|
|
2017-07-11 |
2017-07-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
Officer
|
5,553
-4.3%
102.19
567,461
USD
|
5,553
-4.3%
|
102.19
|
567,461
USD
|
|
2017-07-11 |
2017-07-10 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
Officer
|
3,347
-2.5%
101.06
338,248
USD
|
3,347
-2.5%
|
101.06
|
338,248
USD
|
|
2017-07-06 |
2017-07-03 |
PS
Planned sale
|
Wiezorek Jeffrey
SVP Clinical Development
Officer
|
1,201
-5.4%
104.76
125,817
USD
|
1,201
-5.4%
|
104.76
|
125,817
USD
|
|
2017-07-06 |
2017-07-03 |
PS
Planned sale
|
Wiezorek Jeffrey
SVP Clinical Development
Officer
|
8,799
-28.3%
104.26
917,384
USD
|
8,799
-28.3%
|
104.26
|
917,384
USD
|
|
2017-06-26 |
2017-06-26 |
S
Sale
|
WITTE OWEN N.
|
12,500
-14.1%
100.60
1,257,500
USD
|
12,500
-14.1%
|
100.60
|
1,257,500
USD
|
|
2017-06-27 |
2017-06-23 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
2,050
-1.8%
101.19
207,440
USD
|
2,050
-1.8%
|
101.19
|
207,440
USD
|
|
2017-06-27 |
2017-06-23 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
2,950
-2.5%
100.54
296,593
USD
|
2,950
-2.5%
|
100.54
|
296,593
USD
|
|
2017-06-26 |
2017-06-23 |
PS
Planned sale
|
WITTE OWEN N.
|
12,500
-12.3%
100.00
1,250,000
USD
|
12,500
-12.3%
|
100.00
|
1,250,000
USD
|
|
2017-06-16 |
2017-06-16 |
S
Sale
|
CHAMPSI FARAH
|
5,450
-100.0%
88.11
480,200
USD
|
5,450
-100.0%
|
88.11
|
480,200
USD
|
|
2017-06-16 |
2017-06-14 |
S
Sale
|
CHAMPSI FARAH
|
15,000
-19.1%
90.40
1,356,000
USD
|
15,000
-19.1%
|
90.40
|
1,356,000
USD
|
|
2017-06-16 |
2017-06-14 |
S
Sale
|
Ruchefsky Steven B
|
20,000
-8.9%
89.48
1,789,574
USD
|
20,000
-8.9%
|
89.48
|
1,789,574
USD
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
400
-0.3%
91.08
36,432
USD
|
400
-0.3%
|
91.08
|
36,432
USD
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
1,698
-1.4%
89.76
152,412
USD
|
1,698
-1.4%
|
89.76
|
152,412
USD
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
4,100
-3.3%
89.09
365,269
USD
|
4,100
-3.3%
|
89.09
|
365,269
USD
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
2,502
-2.0%
87.80
219,676
USD
|
2,502
-2.0%
|
87.80
|
219,676
USD
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
900
-0.7%
86.42
77,778
USD
|
900
-0.7%
|
86.42
|
77,778
USD
|
|
2017-06-12 |
2017-06-09 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
400
-0.3%
84.81
33,924
USD
|
400
-0.3%
|
84.81
|
33,924
USD
|
|
2017-06-09 |
2017-06-08 |
S
Sale
|
DOUMANI ROY
|
5,000
-3.2%
84.53
422,634
USD
|
5,000
-3.2%
|
84.53
|
422,634
USD
|
|
2017-06-09 |
2017-06-07 |
S
Sale
|
DOUMANI ROY
|
10,000
-6.1%
84.46
844,621
USD
|
10,000
-6.1%
|
84.46
|
844,621
USD
|
|
2017-06-05 |
2017-06-01 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
|
2,400
-11.4%
72.45
173,880
USD
|
2,400
-11.4%
|
72.45
|
173,880
USD
|
|
2017-05-10 |
2017-05-10 |
B
Purchase
|
JENKINSON PAUL L
Chief Financial Officer
Officer
|
3,000
+inf%
72.59
217,770
USD
|
3,000
+inf%
|
72.59
|
217,770
USD
|
|
2017-05-10 |
2017-05-10 |
PP
Planned purchase
|
JENKINSON PAUL L
Chief Financial Officer
Officer
|
450
+6.4%
72.57
32,657
USD
|
450
+6.4%
|
72.57
|
32,657
USD
|
|
2017-05-11 |
2017-05-09 |
B
Purchase
|
Nussbaum Ran
Non-Executive Director
|
2,632
+inf%
68.94
181,450
USD
|
2,632
+inf%
|
68.94
|
181,450
USD
|
|
2017-05-11 |
2017-05-09 |
B
Purchase
|
Nussbaum Ran
Non-Executive Director
|
1,029
+inf%
69.17
71,176
USD
|
1,029
+inf%
|
69.17
|
71,176
USD
|
|
2017-05-11 |
2017-05-09 |
B
Purchase
|
Nussbaum Ran
Non-Executive Director
|
2,651
+inf%
69.17
183,370
USD
|
2,651
+inf%
|
69.17
|
183,370
USD
|
|
2017-05-11 |
2017-05-09 |
B
Purchase
|
Nussbaum Ran
Non-Executive Director
|
3,520
+inf%
69.17
243,478
USD
|
3,520
+inf%
|
69.17
|
243,478
USD
|
|
2017-05-10 |
2017-05-09 |
B
Purchase
|
Ruchefsky Steven B
Non-Executive Director
|
1,400
+0.6%
69.50
97,300
USD
|
1,400
+0.6%
|
69.50
|
97,300
USD
|
|
2017-05-09 |
2017-05-09 |
B
Purchase
|
Belldegrun Arie
Chairman, President and CEO
Executive Director
|
17,000
+24.8%
68.57
1,165,690
USD
|
17,000
+24.8%
|
68.57
|
1,165,690
USD
|
|
2017-05-09 |
2017-05-09 |
B
Purchase
|
BONDERMAN DAVID
Non-Executive Director
|
3,815
+0.2%
70.15
267,622
USD
|
3,815
+0.2%
|
70.15
|
267,622
USD
|
|
2017-05-09 |
2017-05-09 |
B
Purchase
|
BONDERMAN DAVID
Non-Executive Director
|
46,185
+2.0%
68.84
3,179,375
USD
|
46,185
+2.0%
|
68.84
|
3,179,375
USD
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
Chang David D
EVP, R&D, Chief Medical Off.
Officer
|
300
-0.6%
83.36
25,008
USD
|
300
-0.6%
|
83.36
|
25,008
USD
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
Chang David D
EVP, R&D, Chief Medical Off.
Officer
|
5,905
-10.5%
82.60
487,753
USD
|
5,905
-10.5%
|
82.60
|
487,753
USD
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
Chang David D
EVP, R&D, Chief Medical Off.
Officer
|
13,795
-19.7%
81.84
1,128,983
USD
|
13,795
-19.7%
|
81.84
|
1,128,983
USD
|
|
2017-05-03 |
2017-05-01 |
PS
Planned sale
|
Kim Helen Susan
EVP, Business Development
Officer
|
2,400
-11.4%
82.12
197,088
USD
|
2,400
-11.4%
|
82.12
|
197,088
USD
|
|
2017-05-01 |
2017-04-28 |
S
Sale
|
CHAMPSI FARAH
Non-Executive Director
|
2,617
-34.5%
82.59
216,138
USD
|
2,617
-34.5%
|
82.59
|
216,138
USD
|
|
2017-05-01 |
2017-04-27 |
S
Sale
|
CHAMPSI FARAH
Non-Executive Director
|
16,551
-68.6%
82.77
1,369,926
USD
|
16,551
-68.6%
|
82.77
|
1,369,926
USD
|
|
2017-04-26 |
2017-04-26 |
S
Sale
|
CHAMPSI FARAH
|
200
-0.8%
83.06
16,612
USD
|
200
-0.8%
|
83.06
|
16,612
USD
|
|
2017-04-26 |
2017-04-26 |
S
Sale
|
CHAMPSI FARAH
|
51,112
-67.8%
82.72
4,227,985
USD
|
51,112
-67.8%
|
82.72
|
4,227,985
USD
|
|
2017-04-27 |
2017-04-25 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
3,742
-3.1%
82.87
310,100
USD
|
3,742
-3.1%
|
82.87
|
310,100
USD
|
|
2017-04-27 |
2017-04-25 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
5,545
-4.4%
82.14
455,466
USD
|
5,545
-4.4%
|
82.14
|
455,466
USD
|
|
2017-04-27 |
2017-04-25 |
PS
Planned sale
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
5,713
-4.3%
80.89
462,125
USD
|
5,713
-4.3%
|
80.89
|
462,125
USD
|
|
2017-04-26 |
2017-04-25 |
S
Sale
|
CHAMPSI FARAH
|
15,316
-16.9%
83.29
1,275,670
USD
|
15,316
-16.9%
|
83.29
|
1,275,670
USD
|
|
2017-04-26 |
2017-04-25 |
S
Sale
|
CHAMPSI FARAH
|
31,467
-25.7%
82.56
2,597,916
USD
|
31,467
-25.7%
|
82.56
|
2,597,916
USD
|
|
2017-04-26 |
2017-04-24 |
S
Sale
|
CHAMPSI FARAH
|
25,818
-17.4%
82.34
2,125,854
USD
|
25,818
-17.4%
|
82.34
|
2,125,854
USD
|
|
2017-04-17 |
2017-04-17 |
S
Sale
|
CHAMPSI FARAH
|
100
-0.1%
83.06
8,306
USD
|
100
-0.1%
|
83.06
|
8,306
USD
|
|
2017-04-17 |
2017-04-17 |
S
Sale
|
CHAMPSI FARAH
|
43,001
-22.5%
82.48
3,546,722
USD
|
43,001
-22.5%
|
82.48
|
3,546,722
USD
|
|